Greenlight Re reveals Click2Sure investment

Firm’s new innovation arm makes third investment in less than a month

Greenlight Re reveals Click2Sure investment

Insurance News

By Gabriel Olano

Greenlight Re Innovations, part of specialist P&C reinsurer Greenlight Capital Re, has invested in the digital insurance platform, Click2Sure.

South Africa-based Click2Sure has developed a comprehensive digital platform for distributing, managing, and purchasing insurance at the point of sale. The platform’s API-first approach allows easy creation and deployment of custom insurance products through digital channels.

Click2Sure was launched in 2017 by serial entrepreneurs Daniel Guasco and Jacques Van Niekerk. Guasco was previously CEO of Groupon South Africa and, prior to that, was the founding director of online group buying website Twangoo. Meanwhile, Van Niekerk has worked as chief technology officer for several e-commerce companies in South Africa including Takealot, Mr. Delivery, and Prodigy Finance.

“We are pleased to be partnering with Click2sure and support Daniel and Jacques as they develop new ways for companies to engage and provide value to their customers,” said Greenlight Re CEO Simon Burton. “The Click2sure platform enables a radical transformation of the customer experience and a cost-effective way to deliver insurance products to under-served marketplaces.”

This is the third investment announced by Greenlight Re Innovations, which was launched in March 2018 to seek technology and innovation opportunities relating to the reinsurance and insurance markets.

In late September, it unveiled a strategic investment in Galileo Platforms, a Hong Kong-based insurance and reinsurance platform as a service (PAAS) business which focuses on emerging markets in Asia. Earlier this month, it announced an investment in Sana Benefits, an Austin, Texas based third-party administrator (TPA) focused on the rapidly growing self-insured health market in the United States.

Related Stories

Keep up with the latest news and events

Join our mailing list, it’s free!